Geftistar 250 mg Tablet
13,94$
10,88$
Geftistar 250 mg Tablet is an effective treatment option for adults diagnosed with non-small cell lung cancer (NSCLC) that has metastasized to other areas of the body, particularly in patients exhibiting abnormal epidermal growth factor receptor (EGFR) genes who have not previously undergone cancer therapy. This targeted therapy works by inhibiting the signals that promote cancer cell growth, thereby slowing disease progression and improving outcomes for those affected. However, it is essential to note that Geftistar is not recommended for children or adolescents due to insufficient data regarding its safety and efficacy in these younger populations. Potential side effects may include gastrointestinal disturbances and skin reactions, underscoring the importance of monitoring during treatment. Patients should discuss their medical history and any concurrent medications with their healthcare provider to avoid adverse interactions. As with any medication, adhering to the prescribed dosage and attending regular follow-up appointments is crucial for maximizing the therapeutic benefits of Geftistar 250 mg. For those seeking a promising approach to managing advanced NSCLC, Geftistar offers a tailored solution grounded in the latest advancements in cancer treatment. Always consult your healthcare professional for personalized advice and treatment options.
Quantité
Active Pharmaceutical Ingredient
Uses
• Geftistar 250 mg tablet is primarily used in the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer affects a large number of cells in the lungs and is known for its varied subtypes. By targeting specific cellular pathways, Geftistar 250 mg tablet helps to inhibit the growth and spread of cancerous cells. This targeted approach can lead to improved patient outcomes and management of the disease.
• In patients diagnosed with advanced non-small cell lung cancer, Geftistar 250 mg tablet serves as an effective therapeutic option. It is often prescribed when the cancer has progressed or is not amenable to surgical intervention. The medication works by blocking certain proteins that promote tumor growth, thereby slowing disease progression. This can provide patients with a better quality of life during their treatment journey.
• Geftistar 250 mg tablet may also be utilized in combination with other treatments for non-small cell lung cancer. In many cases, oncologists recommend it as part of a comprehensive treatment plan that includes chemotherapy or radiation therapy. By incorporating Geftistar 250 mg tablet, the overall effectiveness of the treatment regimen can be enhanced. This collaborative approach helps to maximize the chances of controlling the cancer.
• For patients who have experienced recurrence of non-small cell lung cancer, Geftistar 250 mg tablet can offer a vital option for management. It is designed to be effective even in cases where the cancer returns after initial treatment. By providing a targeted mechanism of action, Geftistar 250 mg tablet can help in retarding the growth of recurrent tumors. This can be particularly beneficial in maintaining patient health and extending survival.
Benefits
Geftistar Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Geftistar 250 Tablet may help to slow the progression of cancer.
Geftistar 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
Geftistar Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, Geftistar 250 mg Tablet may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
How To Use
It is recommended to consume Geftistar 250 mg Tablet with or without food. Be sure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.
Safety Advice
• Alcohol: The use of alcohol is generally not recommended while taking Geftistar 250 mg Tablet as it may increase the risk of liver damage. It is advisable to either abstain from alcohol or limit your alcohol intake while taking any medication.
• Kidney: Geftistar 250 mg Tablet is considered safe for patients with mild to moderate kidney disease and no dose adjustment of Geftistar 250 mg is required. However, people with severe kidney disease are advised not to take Geftistar 250 Tablet Tablet. To ensure the safety and effectiveness of your treatment, it is important to have an open discussion with your doctor about all your medical conditions and medications.
• Breastfeeding: It is not advisable to breast-feed while taking Geftistar 250 Tablet as this may cause harm to the baby. Geftistar 250 mg Tablet can pass into breast milk and cause adverse effects. If you are currently breastfeeding and using Geftistar Tablet, it is important to discuss with your doctor the potential risks and benefits of continuing to breastfeed. Your doctor will help you make the decision that is best for you and your baby.
• Liver: Geftistar 250 mg Tablet is considered safe for patients with mild to moderate liver disease, and there is no need to adjust the dose of Geftistar Tablet. However, people with severe liver disease should not use Geftistar 250 mg Tablet. It is important to have an open discussion with your doctor about your medical conditions and medications to ensure that the treatment plan is appropriate for you.
• Pregnancy: Geftistar 250 mg Tablet may be unsafe during pregnancy as animal studies suggest that it may harm the developing fetus. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Geftistar 250 mg Tablet while pregnant. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Driving: Geftistar 250 mg Tablet may cause dizziness, drowsiness, and problems with concentration and coordination, which may impair your ability to drive a vehicle safely. It is important that you follow your doctor's instructions and take the necessary measures, such as avoiding driving or operating heavy machinery, if you experience any of these side effects caused by Geftistar Tablet.